You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

opdivo

Showing 1 - 25 of 731
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)

Not yet recruiting
  • Melanoma
  • ABP 206
  • +2 more
  • (no location specified)
Jun 8, 2023

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • (no location specified)
Aug 28, 2023

Follicular Lymphoma Trial in Australia (Opdivo)

Active, not recruiting
  • Follicular Lymphoma
  • Opdivo
  • Ballarat, Victoria, Australia
  • +4 more
Jan 30, 2023

Pediatric Cancer Trial (Nivolumab)

Approved for marketing
  • Pediatric Cancer
  • Nivolumab
  • (no location specified)
Nov 17, 2021

Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma

Recruiting
  • Mesothelioma, Malignant
    • Shinjuku-ku, Tokyo, Japan
      Local Institution
    Apr 5, 2022

    Melanoma, Metastatic Melanoma Trial in Boston (CDX-301, NEOVAX, Nivolumab)

    Recruiting
    • Melanoma
    • Metastatic Melanoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 12, 2023

    Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Combination 5-azacytidine and nivolumab
    • +2 more
    • (no location specified)
    Dec 7, 2022

    Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

    Not yet recruiting
    • Advanced Renal Cell Carcinoma
    • (no location specified)
    Jun 23, 2023

    Ovarian Cancer Trial in Boston (drug, biological, procedure)

    Recruiting
    • Ovarian Cancer
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 11, 2022

    Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

    Not yet recruiting
    • Neoplasms
    • +2 more
    • Nivolumab Injection [Opdivo]
    • (no location specified)
    Jul 19, 2023

    HIV I Infection Trial in Melbourne (Nivolumab 10 MG/ML [Opdivo], Saline)

    Not yet recruiting
    • HIV I Infection
    • Nivolumab 10 MG/ML [Opdivo]
    • Saline
    • Melbourne, Victoria, Australia
      Alfred Hospital - Department of Infecious Diseases
    May 16, 2022

    Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

    Not yet recruiting
    • Melanoma
    • Urothelial Carcinoma
    • Berlin, Germany
      Local Institution - 0001
    Aug 9, 2022

    Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Metastatic Renal Cell Carcinoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 25, 2023

    Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)

    Recruiting
    • Prostate Cancer
    • Prostate Disease
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 11, 2022

    Breast Cancer Trial in Boston, Pittsburgh, Dallas (Nivolumab, Ipilimumab)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Boston, Massachusetts
    • +2 more
    Oct 21, 2022

    Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)

    Enrolling by invitation
    • Malignant Ascites
    • Taichung, Please Select, Taiwan
      China Medical University Hospital
    Feb 16, 2023

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (Nivolumab, SAbR)

    Terminated
    Has Results
    • Metastatic Clear Cell Renal Cell Carcinoma
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jul 12, 2022

    NSCLC Trial in Durham (Nivolumab, Ipilimumab, Paclitaxel)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Durham, North Carolina
      Duke University Medical Center
    Apr 22, 2022

    Hepatocellular Carcinoma Trial in Philadelphia (Abemaciclib, Nivolumab)

    Terminated
    Has Results
    • Hepatocellular Carcinoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Nov 17, 2022

    Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)

    Not yet recruiting
    • Refractory Tumor
    • Solid Tumor
    • Dendritic Cell Vaccine
    • +2 more
    • Kaohsiung, Taiwan
    • +2 more
    Mar 2, 2023

    Bladder Cancer Trial in United States (Nivolumab, Nivolumab/Lirilumab)

    Completed
    Has Results
    • Bladder Cancer
    • Tampa, Florida
    • +7 more
    Nov 4, 2022

    Meningiomas Trial in Boston (Nivolumab - 240 mg, Ipilimumab - 1 mg/kg, Nivolumab - 480 mg)

    Recruiting
    • Meningiomas
    • Nivolumab - 240 mg
    • +4 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 3, 2022

    Endometrial Tumors, Endometrial Cancer Trial in Seoul (Nivolumab)

    Not yet recruiting
    • Endometrial Neoplasms
    • Endometrial Cancer
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    Mar 21, 2023

    Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,

    Recruiting
    • Metastatic Gastric Cancer
    • +2 more
    • New York, New York
      Bureau for Cancer Research
    May 10, 2023